Shape Memory Medical Inc. announced the first European patient enrollment in the AAA-SHAPE pivotal trial. The patient was ...

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the first enrollment in Europe in the AAA-SHAPE Pivotal Trial, the Company's prospective, ...

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the first enrollment in Europe in the AAA-SHAPE Pivotal Trial, the Company's prospective, multi ...

Serenity Medical announced the publication of 1-year results of the RIVER study by Athos Patsalides, MD, et al in Journal of N ...

This clinical trial of PathMaker's MyoRegulator ® investigational device in individuals with ALS will be conducted ... The CALM study (NCT06649955) is a single-site, open-label trial to further ...

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...

H. Lundbeck A/S (Lundbeck) today announced that amlenetug has received Fast Track designation from the United States (US) Food and Drug Administration (FDA).

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...